phorbol 12,13-dibutyrate has been researched along with Breast Neoplasms in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (27.78) | 18.7374 |
| 1990's | 6 (33.33) | 18.2507 |
| 2000's | 7 (38.89) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acs, P; Ahmad, S; Blumberg, PM; Bogi, K; Glazer, RI; Kozikowski, AP; Lewin, NE; Ma, D; Modarres, S; Wang, S; Yao, J | 1 |
| Ramakrishnan, R; Rathinavelu, A; Zell, JA | 1 |
| Kruger, JS; Reddy, KB | 1 |
| Krebs, CE; Liu, DS; Liu, SJ | 1 |
| Brooks, C; Bulun, SE; Chen, D; Innes, J; Li, N; Lin, Z; Lu, M; Reierstad, S | 1 |
| Collins, M; McKay, I; Rozengurt, E; Taylor-Papadimitriou, J | 1 |
| Budworth, J; Gescher, A | 1 |
| Fine, RL; Harrison, SD; Sachs, CW; Safa, AR | 1 |
| Chen, ZH; Gopalakrishna, R; Gundimeda, U | 1 |
| deFazio, A; Lee, CS; Ormandy, CJ; Sutherland, RL | 1 |
| Basu, A | 1 |
| Malavé, A; Ramakrishnan, R; Rathinavelu, A; Zell, JA | 1 |
| Epstein, RJ; Gulliford, T; Huang, G; Ouyang, X; Smith, G; Zhang, H | 1 |
| Arpin, M; Bastiaens, PI; Gautreau, A; Gschmeissner, S; Hughes, WE; Monypenny, J; Ng, T; Parker, PJ; Parsons, M; Verveer, PJ; Zicha, D | 1 |
| Chabner, BA; Fine, RL; Patel, J | 1 |
| Bayard, F; Darbon, JM; Valette, A | 1 |
| Arnold, AJ; Simpson, RU | 1 |
| Costa, SD; Eppenberger, U; Fabbro, D; Küng, W; Regazzi, R | 1 |
18 other study(ies) available for phorbol 12,13-dibutyrate and Breast Neoplasms
| Article | Year |
|---|---|
Modeling, chemistry, and biology of the benzolactam analogues of indolactam V (ILV). 2. Identification of the binding site of the benzolactams in the CRD2 activator-binding domain of PKCdelta and discovery of an ILV analogue of improved isozyme selectivit
Topics: Antineoplastic Agents; Binding Sites; Binding, Competitive; Breast Neoplasms; Cell Division; Crystallography, X-Ray; Enzyme Inhibitors; Female; Humans; Hydrogen Bonding; Indoles; Isoenzymes; Lactams; Lyngbya Toxins; Models, Molecular; Molecular Conformation; Molecular Structure; Mutagenesis, Site-Directed; Protein Kinase C; Tumor Cells, Cultured | 1997 |
Regulation of mdm2 mRNA expression in human breast tumor-derived GI-101A cells.
Topics: Alkaloids; Animals; Base Sequence; Benzophenanthridines; Breast Neoplasms; Diethylstilbestrol; DNA Primers; Flavonoids; Gene Expression Regulation, Neoplastic; Humans; Mitogen-Activated Protein Kinases; Nuclear Proteins; PC12 Cells; Phenanthridines; Phorbol 12,13-Dibutyrate; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tamoxifen; Tumor Cells, Cultured | 2002 |
Distinct mechanisms mediate the initial and sustained phases of cell migration in epidermal growth factor receptor-overexpressing cells.
Topics: Breast Neoplasms; Cell Division; Cell Line, Tumor; Cell Movement; ErbB Receptors; Flavonoids; Gene Expression Regulation, Neoplastic; Humans; Indoles; Intracellular Signaling Peptides and Proteins; Maleimides; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinases; Myosin-Light-Chain Kinase; Phorbol 12,13-Dibutyrate; Phosphorylation; Protein Kinase C; Protein Kinase C-delta; Protein Serine-Threonine Kinases; rho-Associated Kinases; Transforming Growth Factor alpha; Tyrosine | 2003 |
Proliferation of human breast cancer cells and anti-cancer action of doxorubicin and vinblastine are independent of PKC-alpha.
Topics: Antineoplastic Agents; Breast Neoplasms; Carcinogens; Cell Line, Tumor; Cell Proliferation; Cell Shape; Doxorubicin; Enzyme Activation; Enzyme Inhibitors; Female; Humans; Phorbol 12,13-Dibutyrate; Protein Kinase C-alpha; Staurosporine; Vinblastine | 2007 |
Prostaglandin E(2) induces breast cancer related aromatase promoters via activation of p38 and c-Jun NH(2)-terminal kinase in adipose fibroblasts.
Topics: Activating Transcription Factor 2; Adipose Tissue; Aromatase; Breast Neoplasms; Cyclic CMP; Dinoprostone; Enzyme Activation; Fibroblasts; Humans; JNK Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phorbol 12,13-Dibutyrate; Phosphorylation; Promoter Regions, Genetic; RNA, Messenger; RNA, Small Interfering | 2007 |
An inhibitory effect of tumour promoters on human epithelial cell growth can be dissociated from an effect on junctional communication.
Topics: Breast Neoplasms; Caenorhabditis elegans Proteins; Carrier Proteins; Cell Communication; Cell Division; Cell Line; Cell Transformation, Viral; Epidermal Cells; Epidermis; Humans; Phorbol 12,13-Dibutyrate; Phorbol Esters; Phorbols; Protein Kinase C; Receptors, Cell Surface; Receptors, Drug; Tetradecanoylphorbol Acetate | 1983 |
Differential inhibition of cytosolic and membrane-derived protein kinase C activity by staurosporine and other kinase inhibitors.
Topics: Alkaloids; Breast Neoplasms; Cell Membrane; Cytosol; Humans; Immunoblotting; Indoles; Naphthalenes; Phorbol 12,13-Dibutyrate; Polycyclic Compounds; Protein Kinase C; Staurosporine; Tumor Cells, Cultured | 1995 |
Partial inhibition of multidrug resistance by safingol is independent of modulation of P-glycoprotein substrate activities and correlated with inhibition of protein kinase C.
Topics: Affinity Labels; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain; Breast Neoplasms; Cell Line; Cell Membrane; Cell Survival; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Enzyme Inhibitors; Female; Humans; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Myristoylated Alanine-Rich C Kinase Substrate; Phorbol 12,13-Dibutyrate; Protein Kinase C; Proteins; Rats; Recombinant Proteins; Sphingosine; Substrate Specificity; Tumor Cells, Cultured; Verapamil; Vinblastine | 1995 |
Tamoxifen modulates protein kinase C via oxidative stress in estrogen receptor-negative breast cancer cells.
Topics: Animals; Antioxidants; Breast Neoplasms; Cattle; Cell Division; Cell Membrane; Enzyme Inhibitors; Estrogen Antagonists; Female; Humans; In Vitro Techniques; Oxidative Stress; Phorbol 12,13-Dibutyrate; Protein Kinase C; Rabbits; Receptors, Estrogen; Second Messenger Systems; Tamoxifen; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Vitamin E | 1996 |
Inverse regulation of oestrogen receptor and epidermal growth factor receptor gene expression in MCF-7 breast cancer cells treated with phorbol ester.
Topics: Breast Neoplasms; Carcinogens; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Humans; Phorbol 12,13-Dibutyrate; Receptors, Estrogen; RNA, Messenger; Tumor Cells, Cultured | 1996 |
The involvement of novel protein kinase C isozymes in influencing sensitivity of breast cancer MCF-7 cells to tumor necrosis factor-alpha.
Topics: Antineoplastic Agents; Breast Neoplasms; Bryostatins; Carcinogens; Enzyme Activation; Enzyme Inhibitors; Humans; Indoles; Isoenzymes; Lactams; Lactones; Macrolides; Maleimides; Phorbol 12,13-Dibutyrate; Protein Kinase C; Receptors, Tumor Necrosis Factor; Sensitivity and Specificity; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1998 |
Expression of vascular endothelial growth factor mRNA in GI-101A and HL-60 cell lines.
Topics: Alkaloids; Alternative Splicing; Antineoplastic Agents; Benzophenanthridines; Breast Neoplasms; Diethylstilbestrol; Endothelial Growth Factors; Female; Gene Expression Regulation, Neoplastic; Genetic Variation; HL-60 Cells; Humans; Lymphokines; Phenanthridines; Phorbol 12,13-Dibutyrate; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tamoxifen; Transcription, Genetic; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
Association of ErbB2 Ser1113 phosphorylation with epidermal growth factor receptor co-expression and poor prognosis in human breast cancer.
Topics: Animals; Antibodies, Monoclonal; Becaplermin; Breast Neoplasms; Cells, Cultured; Colforsin; Epidermal Growth Factor; ErbB Receptors; Fluorescent Antibody Technique; Humans; Immunoblotting; Mice; Microscopy, Confocal; Phorbol 12,13-Dibutyrate; Phosphorylation; Phosphoserine; Platelet-Derived Growth Factor; Prognosis; Proto-Oncogene Proteins c-sis; Receptor, ErbB-2; Transfection; Vanadates | 2001 |
Ezrin is a downstream effector of trafficking PKC-integrin complexes involved in the control of cell motility.
Topics: Amino Acid Substitution; Breast Neoplasms; Cell Membrane; Cell Movement; Chromones; Cytoskeletal Proteins; Enzyme Inhibitors; Female; Green Fluorescent Proteins; Humans; Integrin beta1; Isoenzymes; Kinetics; Luminescent Proteins; Microscopy, Confocal; Morpholines; Mutagenesis, Site-Directed; Phorbol 12,13-Dibutyrate; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Phosphothreonine; Protein Kinase C; Protein Kinase C-alpha; Recombinant Fusion Proteins; Tumor Cells, Cultured; Wound Healing | 2001 |
Phorbol esters induce multidrug resistance in human breast cancer cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Carcinogens; Cell Line; Clone Cells; Drug Resistance; Female; Humans; Phorbol 12,13-Dibutyrate; Phorbol Esters; Phosphorylation; Protein Kinase C | 1988 |
Phorbol esters inhibit the proliferation of MCF-7 cells. Possible implication of protein kinase C.
Topics: Breast Neoplasms; Cell Division; Cell Line; Dose-Response Relationship, Drug; Female; Humans; Phorbol 12,13-Dibutyrate; Phorbol Esters; Phorbols; Protein Kinase C; Tetradecanoylphorbol Acetate | 1986 |
Calcium antagonizes 1,25-dihydroxyvitamin D3 inhibition of breast cancer cell proliferation.
Topics: Breast Neoplasms; Calcitriol; Calcium; Cell Division; Cell Line; DNA Replication; Dose-Response Relationship, Drug; Humans; Phorbol 12,13-Dibutyrate; Phorbol Esters | 1986 |
The cytosolic phorboid receptor correlates with hormone dependency in six mammary carcinoma cell lines.
Topics: Breast Neoplasms; Caenorhabditis elegans Proteins; Carrier Proteins; Cell Line; Cytosol; Electrophoresis, Polyacrylamide Gel; Humans; Neoplasms, Hormone-Dependent; Phorbol 12,13-Dibutyrate; Phorbol Esters; Protein Kinase C; Receptors, Drug; Receptors, Immunologic; Subcellular Fractions | 1985 |